Detection rates and sensitivity at different thresholds
| Bilateral breast cancer no ovary or mbc (sensitivity) | Breast–ovary double primary all (sensitivity) | ALL (sensitivity) | |
| Number positive combined | 45/190 (24%) | 49/100 (49%) | 123/336 (37%) |
| Manchester 10% | 44/128 (34%) (98%) | 47/89 (49%) (96%) | 120/265 (45%) (98%) |
| BRCAPRO 10% | 40/158 (25%) (89%) | 48/95 (50.5%) (98%) | 116/295 (39%) (94%) |
| Myriad 10% | 34/84 (40%) (75%) | 48/96 (50%) (98%) | 100/209 (48%) (81%) |
| Manchester 20% | 36/82 (44%) (80%) | 44/73 (60%) (90%) | 109/203 (54%) (89%) |
| BRCAPRO 20% | 40/132 (30%) (89%) | 46/84 (56%) (94%) | 112/256 (44%) (91%) |
| Myriad 20% | 12/18 (67%) (27%) | 40/73 (55%) (90%) | 67/112 (60%) (54%) |